Medicine and Dentistry
Observational Study
100%
Patient with Alzheimer's Disease
100%
Rivastigmine
100%
Alzheimer's Disease
30%
Drug Megadose
30%
Acetylcholinesterase Inhibitor
20%
Titrimetry
20%
Disease
10%
Adverse Event
10%
Symptomatic Treatment
10%
Symptom
10%
Treatment of Alzheimer's Disease
10%
Cholinesterase Inhibition
10%
Activities of Daily Living
10%
Keyphrases
Alzheimer's Disease
100%
Rivastigmine
100%
Acetylcholinesterase Inhibitors (AChEI)
22%
High Dose
22%
Titration
22%
Open-label Extension
22%
Illness
11%
Adverse Effects
11%
Activities of Daily Living
11%
Moderate to Severe
11%
Observational Approach
11%
Treatment Initiation
11%
Long-term Development
11%
Dropout
11%
Global Behavior
11%
Butyl
11%
Global Functioning
11%
Early Initiation
11%
Early Therapy
11%
High-dose Therapy
11%
Severe Alzheimer's Disease
11%
Cholinesterase Inhibition
11%
Biochemistry, Genetics and Molecular Biology
Drug Megadose
100%
Observational Study
100%
Cholinesterase Inhibition
33%
Acetylcholinesterase
33%
Butyrylcholinesterase
33%
Cholinesterase
33%